Terms: = Ovarian cancer AND MALAT1, PRO1073, 378938, Q9UHZ2 AND Diagnosis
5 results:
1. Long Non-Coding RNAs: Bridging cancer-Associated Thrombosis and Clinical Outcome of ovarian cancer Patients.
Marques IS; Tavares V; Savva-Bordalo J; Rei M; Liz-Pimenta J; de Melo IG; Assis J; Pereira D; Medeiros R
Int J Mol Sci; 2023 Dec; 25(1):. PubMed ID: 38203310
[TBL] [Abstract] [Full Text] [Related]
2. METTL16 Inhibits the Malignant Progression of Epithelial ovarian cancer through the lncRNA malat1/
Li C; Liu J; Lyu Y; Ling S; Luo Y
Anal Cell Pathol (Amst); 2023; 2023():9952234. PubMed ID: 37927399
[TBL] [Abstract] [Full Text] [Related]
3. PTCH1-GLI1 Fusion-Positive ovarian Tumor: Report of a Unique Case With Response to Tyrosine Kinase Inhibitor Pazopanib.
Alwaqfi RR; Samuelson MI; Guseva NN; Ouyang M; Bossler AD; Ma D
J Natl Compr Canc Netw; 2021 Sep; 19(9):998-1004. PubMed ID: 34551385
[TBL] [Abstract] [Full Text] [Related]
4. Genomics of a pediatric ovarian fibrosarcoma. Association with the DICER1 syndrome.
Melendez-Zajgla J; Mercado-Celis GE; Gaytan-Cervantes J; Torres A; Gabiño NB; Zapata-Tarres M; Juarez-Villegas LE; Lezama P; Maldonado V; Ruiz-Monroy K; Mendoza-Caamal E
Sci Rep; 2018 Feb; 8(1):3252. PubMed ID: 29459759
[TBL] [Abstract] [Full Text] [Related]
5. Expression and clinical role of long non-coding RNA in high-grade serous carcinoma.
Filippov-Levy N; Cohen-Schussheim H; Tropé CG; Hetland Falkenthal TE; Smith Y; Davidson B; Reich R
Gynecol Oncol; 2018 Mar; 148(3):559-566. PubMed ID: 29310950
[TBL] [Abstract] [Full Text] [Related]